Mooring et al. used several models of liver injury (e.g. chronic CCl4 administration or a CDE-supplement diet) to observe that increased hepatocyte levels and activity of YAP/TAZ were associated with the development of liver inflammation and fibrosis. This evidence concerns the gene YAP1 and Hepatitis.